Amgen announced plans to invest $900 million in expanding its manufacturing facility in Central Ohio. This move will create 350 new jobs, bringing the company’s total investment in the state to over $1.4 billion.

What’s Related

The expansion will increase the total number of jobs at the site to 750. Amgen, which first entered the Columbus Region in 2021, cited Ohio’s business climate, skilled workforce, and strategic location as key factors in its decision to deepen its commitment.

“Today’s investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients around the world have access to our innovative medicines,” said Robert A. Bradway, Chairman and CEO at Amgen.

Ohio Governor Mike DeWine praised the announcement, calling it a sign of the state’s strong foundation for economic development. “We are happy to see Amgen deepen its commitment to our state and look forward to the innovation and economic impact it will drive,” DeWine said.

Since the Tax Cuts and Jobs Act was passed in 2017, Amgen has invested nearly $5 billion in U.S. capital projects, helping drive around $12 billion in economic activity.

The Ohio expansion is part of a bigger U.S. growth push for Amgen, including a $1 billion plan to build another manufacturing site in Holly Springs, North Carolina.